This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Safe and growing: Four dividend stocks that act like growth stocks

By Robbie Citrino for Kapitall.

The typical income stock is a conglomerate whose share price rarely moves, whose business model is steady, and whose dividend pays over 5%. The following five stocks, however, have broken this mold and returned more than 20% this year.

AstraZenica (AZN), the London-based pharmaceutical company rode the biotech boom this year, jumping 24% in six months while holding its 5.22% dividend steady for investors.

Orange (ORAN), a technology solutions and telecom firm based in Paris that currently returns 8% to shareholders in a semiannual dividend. It rose nearly 38% over the course of two quarters by beating analysts' estimates and by earning analysts' upgrades.

The Italian telecom giant, Telecom Italia SpA (TI), has tacked on a whopping 8.9 billion in market cap (or 44%) since December in addition to the 8.8% shareholders received from its dividend despite being downgraded by a variety of analysts.

Rebounding from yearly lows in December, American Capital Agency Corp (AGNC), an American residential REIT has posted solid gains upwards of 20% as analysts pushed their price targets into higher territory. All the while, it kept its staggering 11% dividend in place to entice investors.

These four stocks are exemplary models of what investors are looking for; however, can their share price keep climbing, or will they return to acting like the typical income stock?

Can one investor have it all? Use the links below to start your own research, and tell us what you think in the comments! 

Click on the interactive chart to view data over time. 


1. AstraZeneca PLC ( AZN, Earnings, Analysts, Financials): Develops, and commercializes prescription medicines for cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation diseases worldwide. Market cap at $85.33B, most recent closing price at $68.05.


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs